| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703467 | Null | 0.0107933723273943 | 0.49231649 |
| NSC 711745 | Null | 0.0107933723273943 | 0.38512346 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0107933723273943 | 0.47740197 |
| NSC 726262 | 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one | 0.0107933723273943 | 0.33699875 |
| NSC 737613 | Null | 0.0107933723273943 | 0.33914192 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0107933723273943 | 0.45482832 |
| NSC 749379 | Null | 0.0107933723273943 | 0.37543772 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0107933723273943 | 0.65723546 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0110679092462696 | 0.33109852 |
| NSC 265211 | NSC 265211 | 0.0110679092462696 | 0.22406855 |